167 related articles for article (PubMed ID: 24951336)
1. Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.
De Luca R; Fontana P; Poncet A; de Moerloose P; Pfister RE
Thromb Res; 2014 Aug; 134(2):474-8. PubMed ID: 24951336
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing of neonatal coagulation.
Tan K; Booth D; Newell SJ; Dear PR; Hughes C; Richards M
Clin Lab Haematol; 2006 Apr; 28(2):117-21. PubMed ID: 16630216
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.
Toulon P; Ozier Y; Ankri A; Fléron MH; Leroux G; Samama CM
Thromb Haemost; 2009 Feb; 101(2):394-401. PubMed ID: 19190827
[TBL] [Abstract][Full Text] [Related]
5. Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.
Searles B; Nasrallah F; Graham S; Lajara RB
J Extra Corpor Technol; 2002 Sep; 34(3):178-81. PubMed ID: 12395962
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
[TBL] [Abstract][Full Text] [Related]
7. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.
Neary E; Okafor I; Al-Awaysheh F; Kirkham C; Sheehan K; Mooney C; Foran A; Corcoran JD; Ni Ainle F; Cotter M; McCallion N
Neonatology; 2013; 104(3):222-7. PubMed ID: 24030102
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
Toulon P; Fischer F; Appert-Flory A; Jambou D
Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery.
Choi TS; Greilich PE; Shi C; Wilson JS; Keller A; Kroll MH
Am J Clin Pathol; 2002 Jan; 117(1):74-8. PubMed ID: 11789734
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
Mineo HK; Garabed RB
Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
[TBL] [Abstract][Full Text] [Related]
11. Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients.
Ferring M; Reber G; de Moerloose P; Merlani P; Diby M; Ricou B
Can J Anaesth; 2001 Dec; 48(11):1155-60. PubMed ID: 11744594
[TBL] [Abstract][Full Text] [Related]
12. A cartridge based sensor array platform for multiple coagulation measurements from plasma.
Cakmak O; Ermek E; Kilinc N; Bulut S; Baris I; Kavakli IH; Yaralioglu GG; Urey H
Lab Chip; 2015 Jan; 15(1):113-20. PubMed ID: 25353144
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.
Klein RH; van der Vorst MM; de Wilde RB; Hogenbirk K; de Kam ML; Burggraaf J
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):327-31. PubMed ID: 23337708
[TBL] [Abstract][Full Text] [Related]
14. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
[TBL] [Abstract][Full Text] [Related]
15. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
16. Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory.
Yang W; Hosgood G; Luobikis K; Paul A
Aust Vet J; 2018 Oct; 96(10):379-384. PubMed ID: 30255579
[TBL] [Abstract][Full Text] [Related]
17. Is placental blood a reliable source for the evaluation of neonatal hemostasis at birth?
Raffaeli G; Tripodi A; Manzoni F; Scalambrino E; Pesenti N; Amodeo I; Cavallaro G; Villamor E; Peyvandi F; Mosca F; Ghirardello S
Transfusion; 2020 May; 60(5):1069-1077. PubMed ID: 32315090
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care (POC) measurement of coagulation after cardiac surgery.
Boldt J; Walz G; Triem J; Suttner S; Kumle B
Intensive Care Med; 1998 Nov; 24(11):1187-93. PubMed ID: 9876982
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prothrombin time, activated partial thromboplastin time, and fibrinogen concentration in blood samples collected via an intravenous catheter versus direct venipuncture in dogs.
Maeckelbergh VA; Acierno MJ
Am J Vet Res; 2008 Jul; 69(7):868-73. PubMed ID: 18593235
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
Tseng LW; Hughes D; Giger U
Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
